December 5, 2021
In this featurette from the 2020 Midyear Clinical Meeting, our content matter expert shares the proposed mechanisms for augmented renal clearance in critically ill adult or pediatric patients and evaluate the clinical risk factors for augmented renal clearance.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
December 4, 2021
In this fun, informative presentation format brought to you by the Section of Clinical Specialists and Scientists from the 2020 Midyear Clinical Meeting, content matter experts share GI and nutrition clinical “gems” of information that can be applied across practice settings.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
December 3, 2021
This podcast episode looks at successful opioid stewardship programs and the approaches the programs use to be successful. The moderator and guests discuss methodologies and strategies to help listeners better understand how to implement a successful opioid stewardship program at their site.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
December 2, 2021
The 2020 ASHP Midyear Clinical Meeting was an adjustment for all members who attended, particularly for residency candidates as they navigated a virtual residency showcase and PPS. Join members of the Pharmacy Student Forum and the New Practitioners Forum as they share insights from the 2020 meeting and highlight tips on preparing for the virtual setting and making the most of your experience at the 2021 Midyear Clinical Meeting.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
![Navigating Virtual Midyear 2021: Expert Advice and Must-Watch Sessions]()
December 1, 2021
Join Brittany Tschaen as she sits down with Joe Marchiano and Rena Gosser who will share their lessons learned and best practices for attending the virtual Midyear Clinical Meeting including navigating networking opportunities, attending live sessions and making the most of the virtual platform. Later in the episode, Brittany sits down with three program chairs from the 2021 Midyear Clinical Meeting who will provide an exclusive preview into their presentations prior to the start of the Midyear Clinical Meeting.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
November 30, 2021
In this episode of the Life & Legacy of Joseph A. Oddis, host Daniel Cobaugh sits down with William Zellmer to discuss Dr. Oddis’s career and his contributions to the pharmacy profession.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
November 29, 2021
In this episode of the Life & Legacy of Joseph A. Oddis, host Daniel Cobaugh sits down with Paul Abramowitz, ASHP CEO, to talk about his many fond memories of Dr. Oddis. They discuss how Dr. Oddis’s leadership and vision laid the foundation for ASHP to evolve into the successful organization it is today.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
November 28, 2021
Join our content matter expert from Section of Ambulatory Care Practitioners at the 2020 Midyear Clinical Meeting as they compare appropriate antithrombotic regimens for patients with and without atrial fibrillation who have recently undergone transcatheter aortic valve replacement (TAVR), evaluate the role of dual antiplatelet therapy (DAPT) in patients who have recently undergone TAVR and summarize the prevention and treatment of subclinical leaflet thrombosis in these patients.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
November 28, 2021
Tune in to this podcast episode on acute kidney biomarker testing and how pharmacists may apply acute kidney injury biomarkers in their clinical practice. From the 2020 Midyear Clinical Meeting, content matter experts explore the use of NGAL and TIMP-2*IGFBP-7 in clinical practice.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
November 27, 2021
In this debate style presentation from the 2020 Midyear Clinical Meeting, our content matter experts examine the pros and cons of DOACs and Warfarin in patients with End Stage Renal Disease through a review of the literature. Who will you convince you? Listen in and decide!
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
